(EQH) Axa Equitable Holdings - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 11.987m USD | Total Return: -19.2% in 12m
Avg Turnover: 158M
EPS Trend: 83.0%
Qual. Beats: -1
Rev. Trend: 56.7%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Equitable Holdings, Inc. (EQH) is a diversified financial services firm operating across six distinct business segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. The company provides variable annuities, tax-deferred retirement plans, investment management, and life insurance products to retail, institutional, and municipal clients. Formerly known as AXA Equitable Holdings, the firm was established in 1859 and maintains its headquarters in New York.
The company utilizes a multi-channel distribution strategy, targeting high-net-worth individuals, non-profit entities, and small-to-medium-sized businesses. This business model relies heavily on fee-based income from assets under management and spread-based income from insurance and annuity products. In the diversified financial services sector, firms like EQH often manage interest rate risk by balancing capital-intensive legacy products with capital-light asset management and advisory services.
For a deeper dive into the companys valuation and fundamental metrics, consider reviewing the latest data on ValueRay.
- Assets under management growth at AllianceBernstein drives fee-based revenue and margins
- Interest rate fluctuations impact spread income and valuation of long-term insurance liabilities
- Sales of structured capital strategies annuities influence individual retirement segment earnings
- Shift toward capital-light products reduces exposure to volatile legacy variable annuity guarantees
- Equity market performance dictates asset management fees and variable annuity account values
| Net Income: -822.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.54 > 1.0 |
| NWC/Revenue: -536.6% < 20% (prev -450.7%; Δ -85.90% < -1%) |
| CFO/TA 0.00 > 3% & CFO 840.0m > Net Income -822.0m |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (283.8m) vs 12m ago -9.01% < -2% |
| Gross Margin: 63.55% > 18% (prev 0.69%; Δ 6.29k% > 0.5%) |
| Asset Turnover: 3.79% > 50% (prev 4.87%; Δ -1.09% > 0%) |
| Interest Coverage Ratio: -2.08 > 6 (EBITDA TTM 403.0m / Interest Expense TTM 231.0m) |
| A: -0.20 (Total Current Assets 76.2b - Total Current Liabilities 137b) / Total Assets 310b |
| B: 0.03 (Retained Earnings 8.78b / Total Assets 310b) |
| C: -0.00 (EBIT TTM -480.0m / Avg Total Assets 299b) |
| D: 0.01 (Book Value of Equity 2.48b / Total Liabilities 308b) |
| Altman-Z'' = -1.19 = CCC |
| DSRI: 2.80 (Receivables 25.2b/11.1b, Revenue 11.3b/14.0b) |
| GMI: 1.08 (GM 63.55% / 68.85%) |
| AQI: 0.93 (AQ_t 0.75 / AQ_t-1 0.81) |
| SGI: 0.81 (Revenue 11.3b / 14.0b) |
| TATA: -0.01 (NI -822.0m - CFO 840.0m) / TA 310b) |
| Beneish M = -1.66 (Cap -4..+1) = CCC |
As of May 26, 2026, the stock is trading at USD 42.58 with a total of 2,701,660 shares traded.
Over the past week, the price has changed by +0.00%,
over one month by +2.48%,
over three months by +4.29% and
over the past year by -19.24%.
Axa Equitable Holdings has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy EQH.
- StrongBuy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 57.9 | 36% |
P/E Forward = 4.5851
P/S = 1.0586
P/B = 164.1395
Revenue TTM = 11.3b USD
EBIT TTM = -480.0m USD
EBITDA TTM = 403.0m USD
Long Term Debt = 6.93b USD (from longTermDebt, last quarter)
Short Term Debt = 25.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.4b USD (calculated: Debt 6.93b - CCE 50.4b)
Enterprise Value = 12.0b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = -2.08 (Ebit TTM -480.0m / Interest Expense TTM 231.0m)
EV/FCF = 14.85x (Enterprise Value 12.0b / FCF TTM 807.0m)
FCF Yield = 6.73% (FCF TTM 807.0m / Enterprise Value 12.0b)
FCF Margin = 7.13% (FCF TTM 807.0m / Revenue TTM 11.3b)
Net Margin = -7.26% (Net Income TTM -822.0m / Revenue TTM 11.3b)
Gross Margin = 63.55% ((Revenue TTM 11.3b - Cost of Revenue TTM 4.13b) / Revenue TTM)
Gross Margin QoQ = 90.69% (prev 88.07%)
Tobins Q-Ratio = 0.04 (Enterprise Value 12.0b / Total Assets 310b)
Interest Expense / Debt = 3.33% (Interest Expense 231.0m / Debt 6.93b)
Taxrate = 17.59% (156.0m / 887.0m)
NOPAT = -395.6m (EBIT -480.0m * (1 - 17.59%)) [loss with tax shield]
Current Ratio = 0.56 (Total Current Assets 76.2b / Total Current Liabilities 137b)
Debt / Equity = 25.37 (Debt 6.93b / totalStockholderEquity, last quarter 273.0m)
Debt / EBITDA = -107.8 (out of range, set to none) (Net Debt -43.4b / EBITDA 403.0m)
Debt / FCF = -53.84 (Net Debt -43.4b / FCF TTM 807.0m)
Total Stockholder Equity = 374.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.28% (Net Income -822.0m / Total Assets 310b)
RoE = -219.8% (Net Income TTM -822.0m / Total Stockholder Equity 374.0m)
RoCE = -6.57% (EBIT -480.0m / Capital Employed (Equity 374.0m + L.T.Debt 6.93b))
RoIC = -0.23% (negative operating profit) (NOPAT -395.6m / Invested Capital 173b)
WACC = 7.77% (E(12.0b)/V(18.9b) * Re(10.67%) + D(6.93b)/V(18.9b) * Rd(3.33%) * (1-Tc(0.18)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -7.38%
[DCF] Terminal Value 73.10% ; FCFF base≈1.41b ; Y1≈1.23b ; Y5≈996.3m
[DCF] Fair Price = 211.1 (EV 16.0b - Net Debt -43.4b = Equity 59.4b / Shares 281.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.96 | EPS CAGR: 10.55% | SUE: -1.25 | # QB: -1
Revenue Correlation: 56.68 | Revenue CAGR: 6.80% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.68 | Chg30d=-4.94% | Revisions=-40% | Analysts=12
EPS next Quarter (2026-09-30): EPS=1.82 | Chg30d=-2.86% | Revisions=-40% | Analysts=11
EPS current Year (2026-12-31): EPS=7.06 | Chg30d=-2.19% | Revisions=-43% | GrowthEPS=+25.1% | GrowthRev=+34.1%
EPS next Year (2027-12-31): EPS=8.79 | Chg30d=-0.50% | Revisions=-54% | GrowthEPS=+24.5% | GrowthRev=+9.4%
[Analyst] Revisions Ratio: -54%